204 related articles for article (PubMed ID: 24637464)
1. Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome.
Bull-Hansen B; Cao Y; Berg K; Skarpen E; Rosenblum MG; Weyergang A
J Control Release; 2014 May; 182():58-66. PubMed ID: 24637464
[TBL] [Abstract][Full Text] [Related]
2. Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer.
Bull-Hansen B; Berstad MB; Berg K; Cao Y; Skarpen E; Fremstedal AS; Rosenblum MG; Peng Q; Weyergang A
Oncotarget; 2015 May; 6(14):12436-51. PubMed ID: 26002552
[TBL] [Abstract][Full Text] [Related]
3. Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin.
Weyergang A; Cheung LH; Rosenblum MG; Mohamedali KA; Peng Q; Waltenberger J; Berg K
J Control Release; 2014 Apr; 180():1-9. PubMed ID: 24531010
[TBL] [Abstract][Full Text] [Related]
4. Photochemical internalization (PCI) of HER2-targeted toxins: synergy is dependent on the treatment sequence.
Berstad MB; Weyergang A; Berg K
Biochim Biophys Acta; 2012 Dec; 1820(12):1849-58. PubMed ID: 22981913
[TBL] [Abstract][Full Text] [Related]
5. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
7. Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel.
Selbo PK; Rosenblum MG; Cheung LH; Zhang W; Berg K
PLoS One; 2009 Aug; 4(8):e6691. PubMed ID: 19690617
[TBL] [Abstract][Full Text] [Related]
8. Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity.
Cao Y; Marks JD; Huang Q; Rudnick SI; Xiong C; Hittelman WN; Wen X; Marks JW; Cheung LH; Boland K; Li C; Adams GP; Rosenblum MG
Mol Cancer Ther; 2012 Jan; 11(1):143-53. PubMed ID: 22090420
[TBL] [Abstract][Full Text] [Related]
9. Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties.
Bostad M; Berg K; Høgset A; Skarpen E; Stenmark H; Selbo PK
J Control Release; 2013 Jun; 168(3):317-26. PubMed ID: 23567040
[TBL] [Abstract][Full Text] [Related]
10. Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.
Cao Y; Marks JW; Liu Z; Cheung LH; Hittelman WN; Rosenblum MG
Oncogene; 2014 Jan; 33(4):429-39. PubMed ID: 23376850
[TBL] [Abstract][Full Text] [Related]
11. Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy.
Berstad MB; Cheung LH; Berg K; Peng Q; Fremstedal AS; Patzke S; Rosenblum MG; Weyergang A
Oncogene; 2015 Oct; 34(44):5582-92. PubMed ID: 25684137
[TBL] [Abstract][Full Text] [Related]
12. Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization.
Bostad M; Kausberg M; Weyergang A; Olsen CE; Berg K; Høgset A; Selbo PK
Mol Pharm; 2014 Aug; 11(8):2764-76. PubMed ID: 24960585
[TBL] [Abstract][Full Text] [Related]
13. Photochemical internalization of tumor-targeted protein toxins.
Weyergang A; Selbo PK; Berstad ME; Bostad M; Berg K
Lasers Surg Med; 2011 Sep; 43(7):721-33. PubMed ID: 22057500
[TBL] [Abstract][Full Text] [Related]
14. Light-enhanced VEGF
Weyergang A; Fremstedal AS; Skarpen E; Peng Q; Mohamedali KA; Eng MS; Cheung LH; Rosenblum MG; Waltenberger J; Berg K
J Control Release; 2018 Oct; 288():161-172. PubMed ID: 30217739
[TBL] [Abstract][Full Text] [Related]
15. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
Rosenblum MG; Shawver LK; Marks JW; Brink J; Cheung L; Langton-Webster B
Clin Cancer Res; 1999 Apr; 5(4):865-74. PubMed ID: 10213223
[TBL] [Abstract][Full Text] [Related]
16. Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization.
Berg K; Nordstrand S; Selbo PK; Tran DT; Angell-Petersen E; Høgset A
Photochem Photobiol Sci; 2011 Oct; 10(10):1637-51. PubMed ID: 21773635
[TBL] [Abstract][Full Text] [Related]
17. Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin--quantitative studies in normal rat liver.
Woodhams J; Lou PJ; Selbo PK; Mosse A; Oukrif D; MacRobert A; Novelli M; Peng Q; Berg K; Bown SG
J Control Release; 2010 Mar; 142(3):347-53. PubMed ID: 19932724
[TBL] [Abstract][Full Text] [Related]
18. Photochemical internalization (PCI): a technology for drug delivery.
Berg K; Weyergang A; Prasmickaite L; Bonsted A; Høgset A; Strand MT; Wagner E; Selbo PK
Methods Mol Biol; 2010; 635():133-45. PubMed ID: 20552345
[TBL] [Abstract][Full Text] [Related]
19. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin.
Lund K; Olsen CE; Wong JJW; Olsen PA; Solberg NT; Høgset A; Krauss S; Selbo PK
J Exp Clin Cancer Res; 2017 Dec; 36(1):187. PubMed ID: 29258566
[TBL] [Abstract][Full Text] [Related]
20. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
